Inventor
ANDRES-GIL JOSE IGNACIO
ES34 patents
⚠️ This page may combine multiple inventors who share the name “ANDRES-GIL JOSE IGNACIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
25 patentsUS10150765B2Dec 11, 2018
P2X7 modulators
JANSSEN PHARMACEUTICA NV11 citations92
US10112937B2Oct 30, 2018
P2X7 modulators and methods of use
JANSSEN PHARMACEUTICA NV11 citations92
US9464084B2Oct 11, 2016
P2X7 modulators
JANSSEN PHARMACEUTICA NV16 citations92
US9066946B2Jun 30, 2015
P2X7 modulators
JANSSEN PHARMACEUTICA NV20 citations92
US6583141B1Jun 24, 2003
4,5-dihydro-isoxazole derivatives and their pharmaceutical use
JANSSEN PHARMACEUTICA NV18 citations89
US5994376ANov 30, 1999
1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use for treating allergic, atopic or inflammatory diseases
JANSSEN PHARMACEUTICA NV17 citations83
US11820770B2Nov 21, 2023
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations72
US11225478B2Jan 18, 2022
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations72
US10703749B2Jul 7, 2020
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations72
US7081453B2Jul 25, 2006
Compounds for treating impaired fundic relaxation
JANSSEN PHARMACEUTICA NV6 citations72
US12247027B2Mar 11, 2025
P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations62
US9096596B2Aug 4, 2015
P2X7 modulators
JANSSEN PHARMACEUTICA NV1 citations62
US7501418B2Mar 10, 2009
Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
JANSSEN PHARMACEUTICA NV6 citations60
US7265103B2Sep 4, 2007
Substituted amino isoxazoline derivatives and their use as anti-depressants
JANSSEN PHARMACEUTICA NV3 citations59
US12338243B2Jun 24, 2025
P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations52
US10323032B2Jun 18, 2019
P2X7 Modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9604982B2Mar 28, 2017
P2X7 modulators
JANSSEN PHARMACEUTICA NV0 citations51
US7423048B2Sep 9, 2008
Compounds for treating fundic disaccomodation
JANSSEN PHARMACEUTICA NV0 citations51
US7414048B2Aug 19, 2008
4,5-dihydro-isoxazole derivatives and their pharmaceutical use
JANSSEN PHARMACEUTICA NV0 citations48
US5552399ASep 3, 1996
Substituted tetracyclic azepine derivatives
JANSSEN PHARMACEUTICA NV1 citations48
US7462717B2Dec 9, 2008
C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants
JANSSEN PHARMACEUTICA NV0 citations39
US5691344ANov 25, 1997
Vasoconstrictive substituted dihydropyranopyridines
JANSSEN PHARMACEUTICA NV0 citations39
US7635696B2Dec 22, 2009
Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
JANSSEN PHARMACEUTICA NV0 citations35
US7465741B2Dec 16, 2008
C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
JANSSEN PHARMACEUTICA NV0 citations35
US5773433AJun 30, 1998
Substituted tetracyclic oxazepine and thiazepine derivatives
JANSSEN PHARMACEUTICA NV0 citations32
ANDRES-GIL JOSE IGNACIO
3 patentsUS8158643B2Apr 17, 2012
Substituted diaza-spiro-pyridinone derivatives for use in MCH-1 mediated diseases
ANDRES-GIL JOSE IGNACIO11 citations81
US7169786B2Jan 30, 2007
Isoxazoline derivatives as anti-depressants
ANDRES-GIL JOSE IGNACIO6 citations52
US8329704B2Dec 11, 2012
Substituted pyrazinone derivatives for use in MCH-1 mediated diseases
ANDRES-GIL JOSE IGNACIO0 citations35